166 related articles for article (PubMed ID: 33330057)
1. Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling.
Yu J; Xie M; Ge S; Chai P; Zhou Y; Ruan J
Front Oncol; 2020; 10():580029. PubMed ID: 33330057
[TBL] [Abstract][Full Text] [Related]
2. Immunogenomic-Based Analysis of Hierarchical Clustering of Diffuse Large Cell Lymphoma.
Wang L; Yuan W; Li L; Shen Z; Geng Q; Zheng Y; Zhao J
J Immunol Res; 2022; 2022():9544827. PubMed ID: 35983077
[TBL] [Abstract][Full Text] [Related]
3. Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling.
Zhou X; Qiu S; Nie L; Jin D; Jin K; Zheng X; Yang L; Wei Q
Front Oncol; 2020; 10():1429. PubMed ID: 32974156
[TBL] [Abstract][Full Text] [Related]
4. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L
Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410
[TBL] [Abstract][Full Text] [Related]
5. Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma.
Liu Q; Nie R; Li M; Li L; Zhou H; Lu H; Wang X
Comput Struct Biotechnol J; 2021; 19():4472-4485. PubMed ID: 34471493
[TBL] [Abstract][Full Text] [Related]
6. A signature-based classification of lung adenocarcinoma that stratifies tumor immunity.
Zhang X; Jiang D; Li S; Zhang X; Zheng W; Cheng B
Front Oncol; 2022; 12():1023833. PubMed ID: 36713530
[TBL] [Abstract][Full Text] [Related]
7. An immunogenomic signature for molecular classification in hepatocellular carcinoma.
Zhuang W; Sun H; Zhang S; Zhou Y; Weng W; Wu B; Ye T; Huang W; Lin Z; Shi L; Shi K
Mol Ther Nucleic Acids; 2021 Sep; 25():105-115. PubMed ID: 34401208
[TBL] [Abstract][Full Text] [Related]
8. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
Front Immunol; 2021; 12():685992. PubMed ID: 34262565
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of drug sensitivity, immunological characteristics, and prognosis in melanoma patients using an endoplasmic reticulum stress-associated signature based on bioinformatics and pan-cancer analysis.
Hounye AH; Hu B; Wang Z; Wang J; Cao C; Zhang J; Hou M; Qi M
J Mol Med (Berl); 2023 Oct; 101(10):1267-1287. PubMed ID: 37653150
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
11.
Liu J; Lin J; Wang X; Zheng X; Gao X; Huang Y; Chen G; Xiong J; Lan B; Chen C; Si L; Chen Y
Front Immunol; 2022; 13():725679. PubMed ID: 35844619
[TBL] [Abstract][Full Text] [Related]
12. Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma.
Xue L; Wu P; Zhao X; Jin X; Wang J; Shi Y; Yang X; She Y; Li Y; Li C
Int J Gen Med; 2021; 14():6463-6475. PubMed ID: 34675614
[TBL] [Abstract][Full Text] [Related]
13. Immunity and Extracellular Matrix Characteristics of Breast Cancer Subtypes Based on Identification by T Helper Cells Profiling.
Zhou Y; Tian Q; Gao H; Zhu L; Zhang Y; Zhang C; Yang J; Wang B
Front Immunol; 2022; 13():859581. PubMed ID: 35795662
[TBL] [Abstract][Full Text] [Related]
14. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy.
Xu F; Chen JX; Yang XB; Hong XB; Li ZX; Lin L; Chen YS
Mol Ther Oncolytics; 2020 Jun; 17():241-249. PubMed ID: 32346613
[TBL] [Abstract][Full Text] [Related]
16. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W
Front Immunol; 2021; 12():557994. PubMed ID: 34220791
[TBL] [Abstract][Full Text] [Related]
17. Development of an Immune-Related Gene Signature for Prognosis in Melanoma.
Zhang JA; Zhou XY; Huang D; Luan C; Gu H; Ju M; Chen K
Front Oncol; 2020; 10():602555. PubMed ID: 33585219
[TBL] [Abstract][Full Text] [Related]
18. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
[TBL] [Abstract][Full Text] [Related]
19. Classification of Osteosarcoma Based on Immunogenomic Profiling.
Wang X; Wang L; Xu W; Wang X; Ke D; Lin J; Lin W; Bai X
Front Cell Dev Biol; 2021; 9():696878. PubMed ID: 34336848
[TBL] [Abstract][Full Text] [Related]
20. Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization.
Cui Z; Liang Z; Song B; Zhu Y; Chen G; Gu Y; Liang B; Ma J; Song B
Front Endocrinol (Lausanne); 2023; 14():1180732. PubMed ID: 37229449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
